Overview

* Accuray ( ARAY ) fiscal Q4 revenue up 14% yr/yr, beating analyst expectations, per LSEG data

* Fiscal 2025 revenue rises 3% to $458.5 mln, net loss at $1.6 mln

* Co completes debt refinancing, issues FY26 guidance of $471-485 mln revenue

Outlook

* Accuray ( ARAY ) expects FY26 revenue between $471 mln and $485 mln

* Company forecasts FY26 adjusted EBITDA of $31 mln to $35 mln

* Accuray ( ARAY ) cites supply chain and economic conditions as potential challenges

Result Drivers

* SERVICE REVENUE GROWTH - Service revenue increased by 4% to $56.8 mln, compared to $54.6 mln in the prior year qtr, contributing positively to the overall performance

* PRODUCT REVENUE DECLINE - Product revenue fell by 11% to $70.7 mln, down from $79.7 mln in the prior year qtr

* GROSS PROFIT IMPROVEMENT - Gross profit margin improved to 30.6% from 28.6% in the prior year qtr, despite a decline in net revenue

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q4 Beat $127.54 $123.80

Revenue mln mln (4

Analysts

)

Q4 EPS $0.01

Q4 Net $1.12

Income mln

Q4 Basic $0.01

EPS

Q4 Gross $38.98

Profit mln

Q4 $4.23

Income mln

From

Operatio

ns

Q4 $34.74

Operatin mln

g

Expenses

Analyst Coverage

* The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 4 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the advanced medical equipment & technology peer group is "buy."

* Wall Street's median 12-month price target for Accuray Inc ( ARAY ) is $4.25, about 65.2% above its August 12 closing price of $1.48

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)